Dr. Cathy Spong became NICHD’s acting director on October 1, 2015. Here she shares her plans for the year and her thoughts on what makes NICHD so unique.
Infants exposed in the womb to a drug used to treat HIV and reduce the transmission of HIV from mother to child, may have lower bone mineral content than those exposed to other anti-HIV drugs, according to a National Institutes of Health study.
Current standards for ultrasound evaluation of fetal growth may lead to misclassification of up to 15 percent of fetuses of minority mothers as being too small, according to a study by researchers at the National Institutes of Health (NIH) and other institutions.
The National Institutes of Health has announced $46 million in research awards for the Human Placenta Project, an initiative to revolutionize understanding of the placenta. The awards will fund technology development and testing to assess placental function throughout pregnancy, with the ultimate goal of improving pregnancy outcomes and lifelong health.
The Safe to Sleep®
campaign launches a Fatherhood Initiative with the Kappa Alpha Psi Fraternity encouraging African American men to share safe sleep messages in their families and communities.
Rehabilitation medicine includes efforts to improve function and minimize impairment due to illnesses or injuries. Learn more about NICHD’s rehabilitation research.